Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN): Baird said they are incrementally positive following a clarification of the April 21 update and conversation with management. The analyst believes Achillion’s HCV assets should remain relevant and was reassured regarding efficacy. Shares are Outperform rated with a $15 price target.
Check Point Software Technologies Ltd. (NASDAQ:CHKP): MKM Partners attributes the 7% pullback today in shares of Check Point to the company’s weaker than expected Q1 bookings, and recommends investors use the pullback to add to positions. The firm believes Q1 could represent the low quarter this year for bookings and reiterates a Buy rating on the name.
DR Horton Inc. (NYSE:DHI): D.R. Horton removed from short-term buy list at Deutsche Bank
News Corp. (NASDAQ:NWSA): News Corp. added to the short-term buy list at Deutsche Bank
The Blackstone Group (NYSE:BX): Argus expects investors to begin focusing less on Blackstone’s mark-to-market fluctuations and more on the growth of its assets under management. The firm also expects the company to benefit from the increased popularity of alternative assets and attractive investment opportunities as global deleveraging continues. The firm reiterates a Buy rating on the stock.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.